Back to News
Market Impact: 0.1
Genprex, Inc. to Present TUSC2 Gene Therapy Research at GSA 2026 Annual Scientific Meeting
Source: Nasdaq
Healthcare & Biotech
Genprex said research conducted through its sponsored research collaboration with Meharry Medical College will be featured at the Gerontological Society of America’s 2026 Annual Scientific Meeting, scheduled for November 4–7 in National Harbor, Maryland. The provided article text does not describe the research findings or their potential implications.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
Ticker Sentiment
GNPX0.30
More News
- Bausch Health raises 2026 outlook as third-quarter adjusted earnings surge 53%
- This hospice services stock is outperforming the S&P 500. Jefferies sees more gains ahead
- Biotechs buck a sluggish IPO market, but investors should tread warily
- Waters’ new AI tool targets one of the pharmaceutical industry’s most tedious tasks
- Dassault Systèmes raises 2026 outlook as revenue growth rebound gathers pace
- Needham initiates Clover Health stock with buy on cohort economics
From AllMind Research
- AllMind Platform Feature Updates - Fall 2026
- AI Credit Covenant Monitoring: From Clause to Review
- AI-Led Expert Interviews vs. Transcript Libraries
- State of M&A and Private Markets, June 2026: A $4.9 Trillion Rebound, Underwritten on Money That Never Got Cheaper
- Quartr Alternatives for Institutional Research Teams